Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 Effect of atorvastatin on circulating solubilized Fas ligand (sFasL) in patients with carotid atherosclerosis. Atorvastatin treatment (open bars) increased sFasL levels in patients with carotid atherosclerosis at four to six weeks. Solid bars = no treatment. Data are expressed as median values.
|
